Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial
Titel:
Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial
Auteur:
Patil, Ritesh Clifton, Guy T. Holmes, Jarrod P. Amin, Asna Carmichael, Mark G. Gates, Jeremy D. Benavides, Linda H. Hueman, Matthew T. Ponniah, Sathibalan Peoples, George E.